17609-89-1Relevant academic research and scientific papers
Hydrogenation of plant polyalkoxybenzene derivatives: convenient access to coenzyme Q0 analogues
Khrustalev, Victor N.,Muravsky, Egor A.,Semenov, Victor V.,Shinkarev, Ilia Yu.,Varakutin, Alexander E.
, p. 599 - 601 (2020)
A technologically advanced protocol has been developed for converting plant allyl(polyalkoxy)benzenes to methyl- and propyl(polyalkoxy)benzenes being intermediates in the syntheses of coenzyme Q0 analogues. The key stage of allyl and benzaldehyde moieties hydrogenation was carried out in a periodical autoclave mode on highly porous ceramic block Pd-catalysts. These catalysts possess large surface area, low hydraulic resistance, significant thermal and mechanical stabililty, multiple cycling and easy regeneration, which can dramatically reduce Pd consumption.
Application of plant allylpolyalkoxybenzenes in synthesis of antimitotic phenstatin analogues
Titov, Ilia Y.,Sagamanova, Irina K.,Gritsenko, Roman T.,Karmanova, Irina B.,Atamanenko, Olga P.,Semenova, Marina N.,Semenov, Victor V.
scheme or table, p. 1578 - 1581 (2011/05/04)
Phenstatin and its derivatives with the modified ring A have been synthesized, using plant allylpolyalkoxybenzenes as a starting material. The targeted molecules were evaluated in a phenotypic sea urchin embryo assay for antiproliferative activity. It was found that phenstatin ring A modifications yielded antimitotic compounds. The most effective myristicin derivative 7d (combretastatin A-2 analogue) was determined to be ca. 10 times more potent than phenstatin, displaying antimitotic tubulin-destabilizing activity at the same concentration range as combretastatins. In contrast to combretastatins, 7d featured the steric stability with potential for further design as anticancer agent.
